Moriyama Y, Tsujimura T, Hashimoto K, Morimoto M, Kitayama H, Kitamura Y, Kanakura Y
Department of Internal Medicine II, Osaka University Medical School, Yamadaoka 2-2, Suita 565, Japan.
J Biol Chem. 1996 Feb 16;271(7):3347-50. doi: 10.1074/jbc.271.7.3347.
The c-kit receptor tyrosine kinase (KIT) is constitutively activated in three different types of neoplastic mast cell lines by naturally occurring mutations that result in substitutions of Val or Tyr for Asp814 in the phosphotransferase domain. In an effort to characterize the role of the Asp814 residue, we have investigated the properties of mutant KITs in which the Asp814 residue was deleted or mutated to a series of other amino acids. With the exception of rare instances, mutant KITs with substitutions of Asp814 were found to be constitutively phosphorylated on tyrosine and activated in the absence of the ligand, stem cell factor (SCF), whereas a deletion mutant lacking Asp814 (KITDel-Asp-814) did not exhibit tyrosine phosphorylation and activation even after treatment with SCF. In addition to constitutive activation, furthermore, both highly activated substitution mutants (KITVal-814 and KITTyr-814) and modestly activated substitution mutants (KITGly-814 and KITHis-814) were continuously degraded in the absence of SCF, whereas wild-type KIT (KITWild) required SCF stimulation to undergo degradation. These results suggested that the Asp814 residue may play a crucial role in regulating enzymatic activity and expression of KIT and that various types of mutations at the Asp814 residue may generate oncogenic protein with constitutive activation and degradation.
c-kit受体酪氨酸激酶(KIT)在三种不同类型的肿瘤性肥大细胞系中通过自然发生的突变而组成性激活,这些突变导致磷酸转移酶结构域中的天冬氨酸814被缬氨酸或酪氨酸取代。为了表征天冬氨酸814残基的作用,我们研究了突变型KIT的特性,其中天冬氨酸814残基被缺失或突变为一系列其他氨基酸。除了罕见的情况外,发现用天冬氨酸814取代的突变型KIT在酪氨酸上组成性磷酸化,并在没有配体干细胞因子(SCF)的情况下被激活,而缺乏天冬氨酸814的缺失突变体(KITDel-Asp-814)即使在用SCF处理后也未表现出酪氨酸磷酸化和激活。此外,除了组成性激活外,高度激活的取代突变体(KITVal-814和KIT Tyr-814)和适度激活的取代突变体(KITGly-814和KITHis-814)在没有SCF的情况下都会持续降解,而野生型KIT(KITWild)需要SCF刺激才能发生降解。这些结果表明,天冬氨酸814残基可能在调节KIT的酶活性和表达中起关键作用,并且天冬氨酸814残基处的各种类型的突变可能产生具有组成性激活和降解的致癌蛋白。